At the IGTP TODAY

News

- Research

A team including researchers at the IGTP confirm new ways to test and treat TB by harnessing the body’s own defences

In new study in a cohort of patients from Southern Europe, researchers including the innovation in Respiratory Infections and Tuberculosis Diagnosis Group at the IGTP have confirmed the importance of exploring immune pathways other than the ones modulated by interferon-gamma, which is the one that has been most studied in work on TB until now. The study published in Frontiers of Immunology has also hinted at ways to differentiate between latent and active TB, a major goal in the battle against the disease.

- Research

Scientists from Germans Trias publish data on the negative effects of vaping on the immune response to tuberculosis infections

Scientists from the Innovation in Respiratory Infections and Tuberculosis Diagnosis Group at the IGTP and the Microbiology Service at the Germans Trias Hospital have published a paper in PLOS One on negative effects of vapour from e-cigarettes on the immune response against tuberculosis (TB). The results describe the effect of the vapour specifically on TB infection and they support the need for policies to reduce exposure to both smoke and e-vapour as part of strategies to control TB.

- Innovation, Projects, Research

A project on diagnostics and clinical management of tuberculosis, led by the IGTP, receives Marie Skłodowska Curie Funding

The project, called "Innovation in Tuberculosis - INNOVA4TB", is promoted and coordinated by the research group Innovation in Respiratory Infections and Tuberculosis Diagnosis, led by Dr Jose Domínguez and Dr Cristina Prat.  The proposal has received more than a million euros in funding from the 2018 call for Marie Skłodowska-Curie (MSCA) actions